Skip to main content

Table 2 Analysis of mice survival after treatment with Bor or vehicle (CTR) by the log-rank test (Mantel–Cox)

From: Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo

Variable

Contrast

Hazard ratio

95% hazard ratio confidence limits

p value

Median survival (weeks)

Lower

Upper

Treatment

CTR vs. Bor

4.1

1.28

13.11

0.0172

5.75 vs. 7.25